Icon Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History

Icon Advisers’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,400	Closed	-$2.46M	–	189
2020 Q3	$2.46M	Hold	4,400	–	–	0.48%	76
2020 Q2	$2.74M	Buy	4,400 +1,400	+47%	+$795K	0.54%	59
2020 Q1	$1.47M	Hold	3,000	–	–	0.32%	109
2019 Q4	$1.13M	Hold	3,000	–	–	0.16%	179
2019 Q3	$832K	Hold	3,000	–	–	0.12%	212
2019 Q2	$939K	Hold	3,000	–	–	0.09%	206
2019 Q1	$1.23M	Hold	3,000	–	–	0.12%	172
2018 Q4	$1.12M	Hold	3,000	–	–	0.12%	168
2018 Q3	$1.21M	Hold	3,000	–	–	0.1%	192
2018 Q2	$1.03M	Hold	3,000	–	–	0.08%	208
2018 Q1	$1.03M	Hold	3,000	–	–	0.08%	212
2017 Q4	$1.13M	Hold	3,000	–	–	0.08%	217
2017 Q3	$1.34M	Buy	+3,000	New	+$1.43M	0.09%	233
2016 Q4	–	Sell	-2,200	Closed	-$884K	–	443
2016 Q3	$884K	Sell	2,200 -6,400	-74%	-$2.57M	0.06%	310
2016 Q2	$3M	Buy	8,600 +6,600	+330%	+$2.54M	0.2%	156
2016 Q1	$721K	Buy	+2,000	New	+$824K	0.05%	255
2014 Q4	–	Sell	-11,900	Closed	-$4.29M	–	346
2014 Q3	$4.29M	Buy	11,900 +5,300	+80%	+$1.78M	0.25%	108
2014 Q2	$1.86M	Buy	+6,600	New	+$1.96M	0.12%	150

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Icon Advisers's REGN Position: Q4 2020 in Review

Icon Advisers sold out of Regeneron Pharmaceuticals (REGN) in Q4 2020, closing a stake of 4,400 shares — an estimated $2.46M sold.

Icon Advisers first reported a position in REGN in Q2 2014 and held it in 18 quarters. The position peaked at $4.29M in Q3 2014. 903 funds tracked by Wall St. Rank hold REGN as of Q4 2020.

Icon Advisers reported no remaining Regeneron Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Icon Advisers sold 4,400 Regeneron Pharmaceuticals shares in Q4 2020, an estimated $2.46M.
Icon Advisers first reported a position in Regeneron Pharmaceuticals in Q2 2014 and held it in 18 quarters.
Icon Advisers's Regeneron Pharmaceuticals position peaked at $4.29M in Q3 2014.
903 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2020.

Based on Icon Advisers's 13F filing for Q4 2020, filed 2 Feb 2021.